Precinct Reporter Group News

Top Menu

  • Precinct Reporter News
  • Food
  • Subscribe
  • Privacy Policy

Main Menu

  • Home
  • About
  • Contact Us
  • Read Our E-Edition
  • ADVERTISE
  • Subscribe
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Precinct Reporter News
  • Food
  • Subscribe
  • Privacy Policy

logo

Precinct Reporter Group News

  • Home
  • About
  • Contact Us
  • Read Our E-Edition
  • ADVERTISE
  • Subscribe
  • Asm. Jackson AB 1079 Bill To Fight Hate

  • Opportunities with Downtown S.B. Revitalization

  • New Push for Black Workers and Rights

  • Edna Noble Celebrates 90th Birthday in Style!

  • 60th Anniversary of Birmingham Church Bombing

Latest PRGNews
Home›Latest PRGNews›Alzheimer’s Decision Has Deeper Impact on Health of Minorities

Alzheimer’s Decision Has Deeper Impact on Health of Minorities

By Precinct Reporter News
April 7, 2022
1020
0
Share:

By Isadore Hall
Special to California Black Media Partners

Last spring, the Food and Drug Administration (FDA) approved the first new Alzheimer’s disease therapy since 2003. For the six million-plus people living with the fatal disease in the United States, the availability of a medicine designed to treat the underlying cause of their ailment was a significant breakthrough.

However, it appears very few of those six million Alzheimer’s patients will receive this promising new treatment because of regulators at the Center for Medicare & Medicaid Services (CMS).

CMS is the federal government office that oversees health coverage of more than 100 million people through Medicare, Medicaid, the Children’s Health Insurance Program, and the Health Insurance Marketplace. One of the agency’s main functions is strengthening and modernizing the Nation’s health care system to provide access to high quality care at lower costs.

In January, the CMS launched a process called a National Coverage Determination (NCD) to decide whether Medicare would pay for this newly approved Alzheimer’s therapy or not. Their draft decision: Medicare, as the insurer of roughly 62 million Americans, would not cover this medicine.

The proposed NCD applies to an entire class of Alzheimer’s drugs, which could impact the current FDA approved drugs, aducanumab, as well as future drug therapies in this class. Given the regulatory governance granted to the FDA by Congressional order, it is my opinion this element of the NCD is over-reaching and creates a divisive relationship between two of the most critical federal agencies in the country, FDA and CMS. This decision would also require certain Alzheimer drugs already in development (which may have different demographic and efficacy profiles) to be subjected to a CED process that lacks its own data and does not take into consideration diversity, inclusion, and efficacy.

Furthermore, and most important, the proposed NCD betrays the commitment articulated by President Biden in his Executive Order on Advancing Racial Equity and Support for Underserved Communities Through the Federal Government.

“Equal opportunity is the bedrock of American democracy, and our diversity is one of our country’s greatest strengths. But for too many, the American Dream remains out of reach. Entrenched disparities in our laws and public policies, and in our public and private institutions, have often denied that equal opportunity to individuals and communities,” Biden states in the document.

“Our country faces converging economic, health, and climate crises that have exposed and exacerbated inequities, while a historic movement for justice has highlighted the unbearable human costs of systemic racism,” the president’s statement continued. “Our Nation deserves an ambitious whole-of-government equity agenda that matches the scale of the opportunities and challenges that we face. It is therefore the policy of my Administration that the Federal Government should pursue a comprehensive approach to advancing equity for all, including people of color and others who have been historically underserved, marginalized, and adversely affected by persistent poverty and inequality.”

I know that CMS is fully aware that Alzheimer’s disease is a devastating disease that affects more than six million Americans, 80% of who are Medicare beneficiaries. Among Americans 65 and older, Blacks have the highest percentage of Alzheimer’s Disease, 13.8 %, according to the Centers of Disease Control and Prevention (CDC). In fact, the Alzheimer’s Association reports that older Blacks are twice as likely to have Alzheimer’s Disease than Whites.

African Americans are also mostly likely to be undiagnosed for Alzheimer’s Disease, according to the National Institutes of Health. Therefore, we are also most likely to be untreated.

This issue is very personal for me.

My grandmother lost her fight to Alzheimer’s Disease in 2017. I often watched her feeling helpless as she suffered from this horrifying and painful disease.

Like my grandma, millions of other grandparents, parents and loved ones bear the burdens of this disease and die from it every day.

What would it take for us to do right by them? For us to make sure that as we search for a cure, people who are living with it are receiving the best possible treatments?

CMS must modify its proposed determination to cover all FDA-approved Alzheimer therapies. This would give patients, social workers and physicians the ability to make collaborative decisions in the best interests of those suffering from Alzheimer’s Disease.

Always Spread Love!

Isadore Hall is a former California State Senator and Assemblymember from the Los Angeles Area. He currently sits on the California Agricultural Labor Relations Board.

Tagsalzheimers diseasehealthimpactLong Beach LeaderMedicareminoritiesprecinct reportertricounty bulletin
Previous Article

Dr. Mildred Henry Shares Key to Good ...

Next Article

Reparations Expert Team to Determine Compensation

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Precinct Reporter News

Related articles More from author

  • Latest PRGNews

    World AIDS Day: Know Your Status

    November 29, 2018
    By Precinct Reporter News
  • Latest PRGNews

    Health Insurance Rates for 2019 to Increase 8.7 Percent

    July 26, 2018
    By Precinct Reporter News
  • Latest PRGNews

    NAACP and NNPA Lead Protest Against Police Brutality

    May 9, 2019
    By Precinct Reporter News
  • Latest PRGNews

    S.B. Coalition Pushes for Policy Reform

    June 11, 2020
    By Precinct Reporter News
  • Latest PRGNews

    Black Moms and Babies Die More, Funding to Save Lives

    March 25, 2021
    By Precinct Reporter News
  • Latest PRGNews

    CAP Pushes Census Count to Meet Heavy Demand Ahead

    April 30, 2020
    By Precinct Reporter News

You might be interested

  • Latest PRGNews

    S.B. NAACP New Vision, Welcomes New Officers

  • Latest PRGNews

    Speed Networking Event–30 Second Success

  • Latest PRGNews

    OC Activists Wait on DA Data

Ads

Advertise with us!

Ads

Ads |

Ads V

ADS III

Find us on Facebook

Ads

Precinct Reporter News Group

Your local news resource for 50 years in the Inland Empire, Orange County, Long Beach and surrounding areas!

To subscribe or advertise, call 909.889.0597

About us

  • Broadcasting & Media Production Company
    357 W. 2nd Street
    San Bernardino, California, CA 92401
  • mailto:sales@precinctreporter.com
  • Recent

  • Popular

  • Asm. Jackson AB 1079 Bill To Fight Hate

    By Precinct Reporter News
    September 21, 2023
  • Opportunities with Downtown S.B. Revitalization

    By Precinct Reporter News
    September 21, 2023
  • New Push for Black Workers and Rights

    By Precinct Reporter News
    September 21, 2023
  • IE/OC Prostate and Breast Cancer, Change the Menu

    By PRGNews
    July 16, 2015
  • Join our Recipe Competition!

    By PRGNews
    July 16, 2015
  • SB Budget Cuts CDBG

    SB CDBG Cuts Have Local Nonprofits Braced for the Worst

    By PRGNews
    July 16, 2015

Follow us

© Powered by Hotspotwebsites.net. All rights reserved.